Kebuzone
Jump to navigation
Jump to search
Clinical data | |
---|---|
Routes of administration | intramuscular |
ATC code | |
Pharmacokinetic data | |
Elimination half-life | 70–100 hours |
Excretion | renal |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.011.560 |
Chemical and physical data | |
Formula | C19H18N2O3 |
Molar mass | 322.364 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Kebuzone (or ketophenylbutazone) is a nonsteroidal anti-inflammatory drug (NSAID) that is used for the treatment of inflammatory conditions such as thrombophlebitis and rheumatoid arthritis (RA).[1][2][3]
References
- ^ Austria-Codex (in German). Vienna: Österreichischer Apothekerverlag. 2018. Rheumesser 3 ml-Ampullen.
- ^ "KEBUZONE". NCATS Inxight: Drugs. Retrieved 2019-02-27.
- ^ Aronson JK (2016). "Kebuzone". Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions (Sixteenth ed.). Amsterdam. p. 405. ISBN 978-0-444-53716-4.
{{cite book}}
: CS1 maint: location missing publisher (link)
Categories:
- CS1 German-language sources (de)
- CS1 maint: location missing publisher
- Articles with short description
- Short description is different from Wikidata
- Articles with changed DrugBank identifier
- Articles with changed ChemSpider identifier
- Articles with changed EBI identifier
- ECHA InfoCard ID from Wikidata
- Articles with changed InChI identifier
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- Ketones
- Pyrazolidindiones
- Nonsteroidal anti-inflammatory drugs
- All stub articles
- Musculoskeletal system drug stubs